B
Bull
Bull · 25%IMCC
$3.63
Scenario price
$0.878
-0.045 (-5.08%)At close
Loading chart…
- High
- 0.920
- Open
- 0.920
- VWAP
- 0.87
- Volume
- 71.63K
- Mkt Cap
- 6.03M
- Low
- 0.800
- Amount
- 62.02K
- EV/EBITDA, TTM
- -0.61
IM Cannabis Corp. is an international cannabis company that provides cannabis products to medical patients in Israel and Germany. The Company's ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of its products throughout the entire value chain. In Germany, the Company’s ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. The Company's brands include The Craft Collection, The Top-Shelf Collection, The Signature Collection, The Full Spectrum Extracts, Roma, The WAGNERS, BLKMKT, LOT420, The PICO collection, and Flower.
AI analysis of IM Cannabis Corp (IMCC)
SellIM Cannabis Corp is not a good buy right now due to significant financial losses and declining stock performance. The current price is $0.88, with a staggering year-to-date change of -98.04%. Additionally, the RSI is at 15.892, indicating the stock is heavily oversold, which may suggest further downside risk.
Valuation Metrics
The current forward P/E ratio for IM Cannabis Corp (IMCC) is 42.37, compared to its 5-year average forward P/E of -0.02.
Alphio AI Price Scenarios for IMCC
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Events Timeline
News
8.509-29PRnewswireIM Cannabis Completes Share Transaction Expected to Boost Shareholders' Equity by C$3 Million
8.509-29NewsfilterIM Cannabis Completes Share Transaction, Expected C$3 Million Increase in Shareholders' Equity
8.509-23PRnewswireIM Cannabis Corp. Regains Nasdaq Compliance
8.509-23NASDAQ.COMIM Cannabis Corp. Prices Direct Offering Raising $1.31 Million
2.009-23PRnewswireIM Cannabis Corp. Completes Sale of 655,000 Shares in Direct Offering
IMCC FAQ — answered by Alphio AI
IM Cannabis Corp. is an international cannabis company that provides cannabis products to medical patients in Israel and Germany. The Company's ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of its products throughout the entire value chain. In Germany, the Company’s ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. The Company's brands include The Craft Collection, The Top-Shelf Collection, The Signature Collection, The Full Spectrum Extracts, Roma, The WAGNERS, BLKMKT, LOT420, The PICO collection, and Flower. It operates in the Consumer Non-Cyclicals sector (MEDICINAL CHEMICALS AND BOTANICAL PRODUCTS industry).
IM Cannabis Corp is not a good buy right now due to significant financial losses and declining stock performance. The current price is $0.88, with a staggering year-to-date change of -98.04%. Additionally, the RSI is at 15.892, indicating the stock is heavily oversold, which may suggest further downside risk.
Community
More ↗No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.